CD8A and neoplasm: The recruitment of CD8+ T cells from the secondary lymphoid organs to the tumor was previously shown to contribute to tumor growth inhibition after blockade with PD-1 Abs since treatment with FTY720 lowered the survival, compared to mice treated with PD-1 Ab alone (9).